|
Volumn 24, Issue 18, 2014, Pages 4490-4495
|
Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease
|
Author keywords
Alzheimer's disease; MAO B; Molecular imaging; PET; Pyrazoline derivatives
|
Indexed keywords
5 (ANTHRACEN 9 YL) 3 PHENYL 4,5 DIHYDRO 1H PYRAZOLE DERIVATIVE;
AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B;
BIOLOGICAL MARKER;
MONOAMINE OXIDASE B INHIBITOR;
PYRAZOLINE DERIVATIVE;
TRACER;
UNCLASSIFIED DRUG;
AMINE OXIDASE (FLAVIN CONTAINING);
MONOAMINE OXIDASE INHIBITOR;
PYRAZOLE DERIVATIVE;
ALDOL REACTION;
ALZHEIMER DISEASE;
ARTICLE;
BINDING AFFINITY;
CATALYST;
CRYSTAL STRUCTURE;
CYCLIZATION;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HYDROGEN BOND;
ISOTOPE LABELING;
LIPOPHILICITY;
MOLECULAR DOCKING;
MOLECULAR IMAGING;
POSITRON EMISSION TOMOGRAPHY;
TRANSESTERIFICATION;
CHEMICAL STRUCTURE;
CHEMISTRY;
DIAGNOSTIC USE;
DOSE RESPONSE;
EARLY DIAGNOSIS;
ENZYMOLOGY;
HUMAN;
METABOLISM;
STANDARD;
STRUCTURE ACTIVITY RELATION;
ALZHEIMER DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EARLY DIAGNOSIS;
HUMANS;
MOLECULAR STRUCTURE;
MONOAMINE OXIDASE;
MONOAMINE OXIDASE INHIBITORS;
POSITRON-EMISSION TOMOGRAPHY;
PYRAZOLES;
REFERENCE STANDARDS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84906964183
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2014.07.085 Document Type: Article |
Times cited : (11)
|
References (24)
|